Pneumonia

Bacterial Pneumonia-Complicating Influenza: Risks, Morbidity, and Mortality

By

Suzanne Bujara

Diagnosing coinfection in pneumonia can be challenging because of timing of the sample collection and false-negative results when the viruses replicate in the lower respiratory tract.

An Inflammatory Response: Cardiovascular Complications of Pneumonia

By

Tori Rodriguez, MA, LPC, AHC

As a result of activating the inflammatory-immune system, pneumonia may trigger cardiovascular complications.

Hospital-Acquired Pneumonia: Challenges in Diagnosis and Management

By

Tori Rodriguez, MA, LPC, AHC

An estimated 55% to 85% of hospital-acquired pneumonia infections involve gram-negative bacteria, while 20% to 30% of cases involve gram-positive cocci.

Delafloxacin Approved for Community-Acquired Bacterial Pneumonia

The FDA has approved the supplemental NDA for Baxdela for the treatment of community acquired bacterial pneumonia in adult patients.

Working Group Recommends Pediatric Pneumonia Definition and Diagnostic Criteria

The working group provided a recommended case definition and ancillary testing methods to diagnose severe pneumonia in field trials.

Dental Care May Prevent Recurrent Pneumonia in Children With Neurologic Impairment

Children with neurologic impairment had lower rates of recurrent severe pneumonia if they practiced dental care as a preventive measure.

Efficacy of Lefamulin vs Moxifloxacin for Legionella CABP

Lefamulin appears to be noninferior in safety and efficacy compared with moxifloxicin in the treatment of community-acquired bacterial pneumonia.

Delafloxacin Effectively Treats Community-Acquired Bacterial Pneumonia in Patients With Diabetes

Researchers conducted a Phase 3 trial of patients with community acquired bacterial pneumonia and diabetes to compare delafloxacin treatment with moxiflocacin.